LM Advisors LLC bought a new position in iShares Biotechnology ETF (NASDAQ:IBB – Free Report) during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm bought 9,479 shares of the financial services provider’s stock, valued at approximately $1,288,000. Several other institutional investors have also […]